Nitric oxide attenuates adhesion molecule expression in human endothelial cells

Area of Science:

• Cardiovascular Biology
• Immunology
• Molecular Medicine

Background:

• Leukocyte adhesion to endothelium is a critical early event in atherosclerosis.
• This process involves adhesion molecules like ICAM-1 and VCM-1.
• Endothelial cells play a central role in regulating these interactions.

Purpose of the Study:

• To investigate the effect of nitric oxide (NO) on ICAM-1 and VCM-1 expression.
• To determine the role of NO in modulating endothelial cell adhesion molecule expression.
• To understand NO's potential in preventing leukocyte adhesion in atherosclerosis.

Main Methods:

• Human umbilical vein endothelial cells (HUVECs) were treated with interleukin-1 beta (IL-1 beta).
• Nitric oxide donor (SIN-1) and scavenger (hemoglobin) were used to modulate NO levels.
• Protein expression was measured by cellular ELISA; mRNA levels by Northern blot.

Main Results:

• IL-1 beta significantly increased ICAM-1 and VCM-1 protein and mRNA expression.
• SIN-1 dose-dependently inhibited IL-1 beta-induced ICAM-1 and VCM-1 expression.
• The inhibitory effect of SIN-1 was reversed by hemoglobin, confirming NO's role.

Conclusions:

• Nitric oxide significantly inhibits the expression of ICAM-1 and VCM-1 in endothelial cells.
• NO may prevent leukocyte adhesion and accumulation by downregulating these adhesion molecules.
• These findings highlight a potential therapeutic role for NO in atherosclerosis.